Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Photo of Mary Szela
Person

Mary Szela

Overview

Edit Overview Section
Number of Current Board & Advisor Roles 7
CB Rank (Person) 98,149
Mary Szela is the CEO & President at TriSalus Life Sciences .

Jobs

Edit Jobs Section
Number of Current Jobs 2
Number of Past Jobs 5
Mary Szela has 2 current jobs as CEO & President at TriSalus Life Sciences and Chief Executive Officer at Aegerion Pharmaceuticals. Additionally, Mary Szela has had 5 past jobs including Chief Executive Office at Novelion Therapeutics.
Organization Name  
Title At Company  
Start Date  
End Date  
Novelion Therapeutics Logo
Novelion Therapeutics
Chief Executive OfficeJan 2016Nov 2017
Melinta Therapeutics Logo
Melinta Therapeutics
Chief Executive OfficerJan 2013Sep 2015
Abbott Logo
Abbott
SVP, Global Strategic Marketing and ServicesAug 1987May 2012
Abbott Logo
Abbott
Abbott’s U.S. Pharmaceutical Businesses——
Abbott Logo
Abbott
SVP, Global Strategic Marketing and Services in the Pharmaceutical Products Group——

Board and Advisor Roles

Edit Board and Advisor Roles Section
Number of Current Board & Advisor Roles 7
Number of Past Board & Advisor Roles 2
Mary Szela holds 7 board and advisor roles including Board Member at Kintai Therapeutics, Board Member at Kura Oncology, and Member of Board at Alimera Sciences.
Organization Name  
Title At Company  
Start Date  
End Date  
Suneva Medical Logo
Suneva Medical
Board MemberJun 2012Jul 2017
Novo Nordisk Logo
Novo Nordisk
directorMar 2015May 2017

Related Hubs

Edit Related Hubs Section
Hub Name  
CB Rank (Hub)  
Oncology Companies With More Than 10 Employees Logo
Oncology Companies With More Than 10 Employees
14,451
Hardware Public Companies With More Than $10M in Revenue Logo
Hardware Public Companies With More Than $10M in Revenue
42,171
Developer Platform Companies that Exited Logo
Developer Platform Companies that Exited
33,676
Biotechnology Public Companies With Less Than $500M in Revenue Logo
Biotechnology Public Companies With Less Than $500M in Revenue
26,066
Biotechnology Public Companies With Fewer Than 50 Employees Logo
Biotechnology Public Companies With Fewer Than 50 Employees
37,058
United States Public Companies With Fewer Than 50 Employees Logo
United States Public Companies With Fewer Than 50 Employees
37,889
Hardware Public Companies With More Than 10 Employees Logo
Hardware Public Companies With More Than 10 Employees
37,742
Developer Platform Companies Logo
Developer Platform Companies
15,672
Hardware Companies With Less Than $50M in Revenue (Top 10K) Logo
Hardware Companies With Less Than $50M in Revenue (Top 10K)
6,665
Developer Platform Companies With Fewer Than 100 Employees Logo
Developer Platform Companies With Fewer Than 100 Employees
20,618

Education

Edit Education Section
Mary Szela studied at University of Illinois Urbana-Champaign and  University of Illinois Urbana-Champaign.

Events

Edit Events Section
Number of Events 1
Mary Szela has participated in 1 event, OrphanDrug Congress USA 2017 on Apr 19, 2017.

Recent News and Activity

Edit Recent News and Activity Section
Number of News Articles 13
News•Feb 2, 2018
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jan 30, 2018
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 16, 2016
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Oct 17, 2014
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Aug 12, 2014
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 27, 2014
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 14, 2014
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 9, 2014
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 28, 2014
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 28, 2014
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
View All
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(d29fb2e 1)
|